PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions

NCT03093818 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

6950

Enrollment

OTHER

Sponsor class

Conditions

Adverse Drug Reaction

Interventions

OTHER: Pharmacogenomic testing

Sponsor

J.J.Swen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]